izpis_h1_title_alt

Sinteza substituiranih N-akriloilpiperidinskih zaviralcev imunoproteasoma
ID Tomažin, Katja (Author), ID Obreza, Aleš (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (1,33 MB)
MD5: A667035D8080233911BE5B1646B7EB52

Abstract
Ubikvitin-proteasomski kompleks v evkariontskih celicah je odgovoren za razgradnjo znotrajceličnih proteinov in posledično za vzdrževanje homeostaze ter nemoteno delovanje celic. Poleg konstitutivnega proteasoma, ki se nahaja v vseh celicah, poznamo še imunoproteasom, ki ga najdemo v celicah imunskega izvora. Le ta nastane pri vnetju in drugih stresnih imunskih odzivih. Kot terapevtsko tarčo ga uporabljajo pri zdravljenju vnetnih, rakavih, avtoimunih in nevrodegenerativnih boleznih. Večina zaviralcev, ki se uporabljajo za zdravljenje, ali so v postopku kliničnega preizkušanja, je neselektivnih, kar je tudi glavni vzrok za številne neželene učinke. Razvoj gre v smeri selektivnih zaviralcev β5i podenote imunoproteasoma, saj bi s tem zmanjšali pojav neželenih učinkov. To je bil tudi namen magistrske naloge. Na osnovni skelet substituiranega piperidina smo pripeli benzil karbamatno zaščito, da smo v drugi stopnji lahko selektivno odstranili t-butiloksikarbonilno zaščitno skupino s sekundarne aminske skupine. Nato smo na prosti aminski skupini tvorili amid s pomočjo sklopitvenih reagentov. Pri odstranjevanju benzil karbamatne zaščitne skupine s katalitskim hidrogeniranjem so bile izgube prevelike, zato smo ostale spojine sintetizirali drugače. Namesto pripenjanja akriloil klorida na piperidinsko aminsko skupino v zadnji stopnji, smo to naredili najprej. Nato smo odstranili t-butiloksikarbonilno zaščito. Sledila je sinteza amida oziroma amina s pomočjo sklopitvenih reagentov. Na prosto aminsko skupino smo pripeli karboksilno kislino, ki smo jo aktivirali s pomočjo sklopitvenega reagenta 1-etil-3-(3-dimetilaminopropil)karbodiimida (EDC). Dodali smo tudi hidroksibenzotriazol (HOBT), da bi zmanjšali verjetnost nastanka stranskih produktov in racemizacije. Tako smo dobili amidne derivate. Za sintezo aminskih derivatov smo uporabili reakcijo reduktivnega aminiranja. Prosto aminsko skupino smo pretvorili v imin in ga reducirali s pomočjo natrijevega acetoksiborohidrata (NaBH(OAc)3). Reakcija je potekala v inertni argonovi atmosferi. Dobili smo sekundarne aminske derivate, ki so po oroševanju z ninhidrinom povzročili obarvanje lis na ploščicah TLC (tankoplastne kromatografije). Uspešno smo sintetizirali devet končnih spojin, ki smo jih biokemijsko ovrednotili z merjenjem rezidualne aktivnosti encima v prisotnosti zaviralcev in izračunali IC50. Dve izmed njih sta mikromolarna zaviralca imunoproteasoma, vendar imata neselektivno delovanje – poleg β5i enote verjetno reverzibilno zavirata še β5, β1i in β1 podenoto.

Language:Slovenian
Keywords:imunoproteasom, zaviralci, kompleks ubikvitin-proteasom, amino(metil)piperidin, β5i podenota
Work type:Master's thesis/paper
Organization:FFA - Faculty of Pharmacy
Year:2020
PID:20.500.12556/RUL-121760 This link opens in a new window
Publication date in RUL:27.10.2020
Views:1034
Downloads:485
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Synthesis of substituted N-acryloylpiperidine immunoproteasome inhibitors
Abstract:
Ubiquitin-proteasome system in eukaryotic cells is the main system for degradation of intracellular proteins and consequently for maintaining homeostasis and cell activity. In addition to the constitutive proteasome 26S, which is present in all cell types, the immunoproteasome is found mainly in cells of immune origin. Expression of immunoproteasome is induced when inflammation and other stressful situations occur. It is used as a therapeutic target for treatment of inflammatory, cancerous, autoimmune and neurodegenerative diseases. Most inhibitors used for treatment, or undergoing a clinical trial, are non-selective, which is the main reason they cause many side effect. Accordingly, development is oriented in the direction of finding inhibitors selective for the β5i subunit, which would reduce the occurrence of side effect. This was also our main goal of the work for the master's thesis. Benzyl carbamate protection was attached to the backbone of the substituted piperidine so that the t-butyloxycarbonyl protecting group could be removed from the secondary amine group in the second step. The amide was then formed on the free amine group using coupling reagents. The other compounds were then synthesized differently, because the losses in the removal of the benzyl carbamate protecting group by catalytic hydrogenation were excessive. Instead of attaching acryloyl chloride to the piperidine amine group in the last step, we did so first. The t-butyloxycarbonyl protection was then removed. The synthesis of amide or amine with the help of coupling reagents followed. A carboxylic acid was attached to the free amine group, which was activated by coupling reagent 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC). We also added Hydroxybenzotriazole (HOBT) to reduce the likelihood of by-product formation and racemization. Thus we obtained amide derivatives. A reductive amination reaction was used for the synthesis of amine derivatives. The free amine group was converted to the imine and reduced with sodium acetoxyborohydrate (NaBH(OAc)3). The reaction took place in an inert argon atmosphere. Secondary amine derivatives were stained with ninhydrin on TLC (amides were not). Nine final compounds were successfully synthesized and biochemically evaluated. We measured residual activity of enzyme in the presence of inhibitor and calculated IC50. Two of them are micromolar immunoproteasome inhibitors. Unfortunately they are non-selective – in addition to the β5i subunit, they probably reversibly inhibit β5, β1i and β1 subunits.

Keywords:immunoproteasome, inhibitors, ubiquitin-proteasome system, amino(methyl)piperidine, β5i subunit

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back